Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro

British Journal of Nutrition

Volumn 101, Issue 7, 2009, Pages 967-971

  Marín Manzano, M Carmen ^a   Ruiz, Raquel ^a   Jiménez, Elisabeth ^a   Rubio, Luis A ^a   Clemente, Alfonso ^a  

^a CSIC   (Spain)

Author keywords

Anti bacterial activity; Biotransformation; Bowman Birk inhibitors; Faecal microbiota; Protease inhibitory activity

Indexed keywords

BOWMAN BIRK INHIBITOR; CHYMOTRYPSIN; PROTEINASE INHIBITOR; TRYPSIN; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTEROIDES; BIFIDOBACTERIUM; BIOTRANSFORMATION; CLOSTRIDIA; COLIFORM BACTERIUM; CONTROLLED STUDY; DIETARY INTAKE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; FECES ANALYSIS; FECES CULTURE; FECES MICROFLORA; FERMENTATION; GASTROINTESTINAL TRACT; IN VITRO STUDY; LACTOBACILLUS; NONHUMAN; PROTEINASE INHIBITION; SOYBEAN; ANIMAL; BACTERIAL COUNT; CHEMISTRY; FECES; INTESTINE; METABOLISM; MICROBIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SWINE;

BACTERIA (MICROORGANISMS); BACTEROIDES; CLOSTRIDIA; ENTEROBACTERIACEAE; SUIDAE;

ANIMALS; ANTICARCINOGENIC AGENTS; COLONY COUNT, MICROBIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FECES; FERMENTATION; INTESTINES; SOYBEANS; SWINE; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

EID: 67449088385     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508057590     Document Type: Article

References (29)

1. Moreno FJ & Clemente A (2008) 2S albumin storage proteins: What makes them food allergens? Open Biochem J 2, 11-23.
2. Pusztai A, Bardocz S & Martin-Cabrejas MA (2004) The mode of action of ANFs on the gastrointestinal tract and its microflora. In Recent Advances of Research in Antinutritional Factors in Legume Seeds and Oilseeds, pp. 87-100 [M Muzquiz, GD Hill, C Cuadrado, MM Pedrosa and C Burbano, editors]. Wageningen, The Netherlands: Wageningen Academic Publishers.
3. Kennedy AR (1998) Chemopreventive agents: Protease inhibitors. Pharmacol Ther 78, 167-209.
4. Clemente A & Domoney C (2006) Biological significance of polymorphism in plant protease inhibitors from the Bowman- Birk class. Curr Prot Pept Sci 7, 201-216.
5. Clemente A & Domoney C (2007) Therapeutic properties of legume protease inhibitors from the Bowman-Birk class. In Recent Progress in Medicinal Plants, vol. 20, pp. 397-417 [JN Govil, VK Singh and RK Sharma, editors]. Houston, TX: Studium Press.
6. Clemente A, Jiménez E, Marín-Manzano MC & Rubio LA (2008) Active Bowman-Birk inhibitors survive gastrointestinal digestion at the terminal ileum of pigs fed chickpea-based diets. J Sci Food Agric 88, 513-521.
7. Clemente A, Vioque J, Sanchez-Vioque R, Pedroche J, Bautista J & Millán F (2000) Factors affecting the in vitro digestibility of chickpea albumins. J Sci Food Agric 80, 79-84.
8. Fernandes AO & Banerji AP (1995) Inhibition of benzopyrene-induced forestomach tumors by field bean protease inhibitor(s). Carcinogenesis 16, 1843-1846.
9. Kennedy AR, Billings PC, Wan XS & Newberne PM (2002) Effects of Bowman-Birk inhibitor on rat colon carcinogenesis. Nutr Cancer 43, 174-186.
10. Lichtenstein GR, Deren JJ, Katz S, Lewis JD, Kennedy AR & Ware JH (2008) Bowman-Birk inhibitor concentrate: A novel therapeutic agent for patients with active ulcerative colitis. Digest Dis Sci 53, 175-180.
11. Domoney C & Welham T (1992) Trypsin inhibitors in Pisum: Variation in amount and pattern of accumulation in developing seed. Seed Sci Res 2, 147-154.
12. Clemente A, MacKenzie DA, Jeenes DJ & Domoney C (2004) The effect of variation within inhibitory domains on the activity of pea protease inhibitors from the Bowman-Birk class. Protein Expression Purif 36, 106-114.
13. Miller ER & Ullrey DE (1987) The pig as a model for human nutrition. Ann Rev Nutr 7, 361-382.
14. Domoney C, Welham T, Sidebottom C & Firmin JL (1995) Multiple isoforms of Pisum trypsin inhibitors result from modification of two primary gene products. FEBS Lett 360, 15-20.
15. Ramasarma PR, Appu Rao AG & Rao DR (1995) Role of disulfide linkages in structure and activity of proteinase inhibitor from Dolichos biflorus. Biochim Biophys Acta 1248, 35-42.
16. Kennedy AR, Billings PC, Maki PA & Newberne P (1993) Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA. Nutr Cancer 19, 191-200.
17. Clemente A, Gee JM, Johnson IT, MacKenzie DA & Domoney C (2005) Pea ( Pisum sativum L.) protease inhibitors from the Bowman-Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro. J Agric Food Chem 53, 8979-8986.
18. St Clair W, Billings P, Carew J, Keller-McGandy C, Newberne P & Kennedy AR (1990) Suppression of dimethylhydrazineinduced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res 50, 580-586.
19. Darmoul D, Gratio V, Devaud H, Lehy T & Laburthe M (2003) Aberrant expression and activation of the thrombin receptor protease- activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 162, 1503-1513.
20. Kennedy AR (1998) The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am J Clin Nutr 68, 1406-1412.
21. Bhatt AS, Takeuchi T, Ylstra B, Ginzinger D, Albertson D, Shuman MA & Craik CS (2003) Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells. Biol Chem 384, 257-266.
22. Yamasaki Y, Satomi S, Murai N, Tsuzuki S & Fushiki T (2003) Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors. J Nutr Sci Vitaminol 49, 27-32.
23. Ware JH, Wan XS, Schechter NM & Kennedy AR (1997) Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch Biochem Biophys 344, 133-138.
24. Billings PC, Brandon DL & Habres JM (1991) Internalization of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Eur J Cancer 27, 903-908.
25. Chen YW, Huang SC, Lin-Shiau SY & Lin JK (2005) Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 26, 1296-1306.
26. Duranti M (2006) Grain legume proteins and nutraceutical properties. Fitoterapia 77, 67-82.
27. Roberfroid M (2007) Prebiotics: The concept revisited. J Nutr 137, 830-837.
28. Blaut M & Clavel T (2007) Metabolic diversity of the intestinal microbiota: Implications for health and disease. J Nutr 137, 751-755.
29. Costabile A, Klinder A, Fava F, Napolitano A, Fogliano V, Leonard C, Gibson G & Tuohy KM (2008) Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: A double-blind, placebo controlled, crossover study. Br J Nutr 99, 110-120.